UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-
16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 28, 2010
Commission File Number 1-32186
___________________
YM BioSciences Inc.
(Translation of registrant's name into English)
Suite 400, Building 11
5045 Orbitor Drive
Mississauga, Ontario
Canada L4W 4Y4
(Address of principal executive offices)
___________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) o
DOCUMENTS FILED
See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| By: /s/ Leonard Vernon |
| Name: Leonard Vernon |
| Title: Vice President, Finance and Administration |
Date: January 28, 2010
EXHIBIT INDEX
Exhibit | Description |
| |
99.1 | Letter dated October 29, 2009 |
99.2 | Letter to Shareholders dated September 25, 2009 |
99.3 | Voting Results from November 20, 2008 Annual General Meeting |
| |
EXHIBIT 99.1
EXHIBIT 99.2
EXHIBIT 99.3
